The landscape of tumor treatment is constantly evolving, with a growing spotlight on identifying novel therapeutic targets for drug development. Traditional therapies often strike rapidly dividing cells, leading to significant side outcomes. However, the emergence of sophisticated genomic profiling techniques has altered our perception of cancer bi